| Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis N Potere, E Valeriani, M Candeloro, M Tana, E Porreca, A Abbate, ... Critical care 24, 1-12, 2020 | 239 | 2020 |
| Targeting the NLRP3 inflammasome in cardiovascular diseases S Toldo, E Mezzaroma, LF Buckley, N Potere, M Di Nisio, G Biondi-Zoccai, ... Pharmacology & therapeutics 236, 108053, 2022 | 149 | 2022 |
| Canakinumab in a subgroup of patients with COVID-19 C Ucciferri, A Auricchio, M Di Nicola, N Potere, A Abbate, F Cipollone, ... The Lancet Rheumatology 2 (8), e457, 2020 | 145 | 2020 |
| The NLRP3 inflammasome inhibitor, OLT1177 (dapansutrile), reduces infarct size and preserves contractile function after ischemia reperfusion injury in the mouse S Toldo, AG Mauro, Z Cutter, BW Van Tassell, E Mezzaroma, ... Journal of Cardiovascular Pharmacology 73 (4), 215-222, 2019 | 111 | 2019 |
| The role of IL-6 and IL-6 blockade in COVID-19 N Potere, A Batticciotto, A Vecchié, E Porreca, A Cappelli, A Abbate, ... Expert review of clinical immunology 17 (6), 601-618, 2021 | 106 | 2021 |
| Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case–control study N Potere, M Di Nisio, D Cibelli, R Scurti, A Frattari, E Porreca, A Abbate, ... Annals of the rheumatic diseases 80 (2), 1-2, 2021 | 71 | 2021 |
| Low density lipoprotein receptor-related protein-1 in cardiac inflammation and infarct healing N Potere, MG Del Buono, AG Mauro, A Abbate, S Toldo Frontiers in cardiovascular medicine 6, 51, 2019 | 70 | 2019 |
| Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications N Potere, MG Del Buono, R Caricchio, PC Cremer, A Vecchie, E Porreca, ... EBioMedicine 85, 2022 | 66 | 2022 |
| The role of NLRP3 inflammasome in pericarditis: potential for therapeutic approaches AG Mauro, A Bonaventura, A Vecchié, E Mezzaroma, S Carbone, ... Basic to Translational Science 6 (2), 137-150, 2021 | 63 | 2021 |
| Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation N Potere, M Di Nisio, G Rizzo, M La Vella, E Polilli, A Agostinone, ... International Journal of Infectious Diseases 100, 421-424, 2020 | 39 | 2020 |
| Alirocumab in acute myocardial infarction: results from the Virginia commonwealth university alirocumab response trial (VCU-AlirocRT) CR Trankle, G Wohlford, LF Buckley, D Kadariya, K Ravindra, R Markley, ... Journal of cardiovascular pharmacology 74 (3), 266-269, 2019 | 35 | 2019 |
| Unsaturated fatty acids to improve cardiorespiratory fitness in patients with obesity and HFpEF: the UFA-preserved pilot study S Carbone, HE Billingsley, JM Canada, D Kadariya, H Medina de Chazal, ... JACC: Basic to Translational Science 4 (4), 563-565, 2019 | 30 | 2019 |
| Developing LRP1 agonists into a therapeutic strategy in acute myocardial infarction N Potere, MG Del Buono, G Niccoli, F Crea, S Toldo, A Abbate International journal of molecular sciences 20 (3), 544, 2019 | 30 | 2019 |
| Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 M Di Nisio, N Potere, M Candeloro, A Spacone, L Pieramati, G Ferrandu, ... European journal of internal medicine 83, 34-38, 2021 | 29 | 2021 |
| An orally available NLRP3 inflammasome inhibitor prevents western diet–induced cardiac dysfunction in mice S Carbone, AG Mauro, A Prestamburgo, MS Halquist, P Narayan, ... Journal of cardiovascular pharmacology 72 (6), 303-307, 2018 | 25 | 2018 |
| Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone N Potere, M Candeloro, E Porreca, S Marinari, C Federici, R Auciello, ... Journal of Thrombosis and Thrombolysis, 1-6, 2022 | 19 | 2022 |
| Prevalence and severity of nonalcoholic fatty liver disease among caregivers of patients with nonalcoholic fatty liver disease cirrhosis MS Siddiqui, S Carbone, R Vincent, S Patel, C Driscoll, FS Celi, ... Clinical Gastroenterology and Hepatology 17 (10), 2132-2133, 2019 | 17 | 2019 |
| NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis N Potere, E Garrad, Y Kanthi, M Di Nisio, G Kaplanski, A Bonaventura, ... Cardiovascular research 119 (11), 2046-2060, 2023 | 16 | 2023 |
| Takotsubo syndrome: diagnostic work-up and clues into differential diagnosis MG Del Buono, N Potere, JG Chiabrando, E Bressi, A Abbate Current Opinion in Cardiology 34 (6), 673-686, 2019 | 16 | 2019 |
| Effects of Obesity and Thrombophilia on the Risk of Abortion in Women Undergoing In Vitro Fertilization M Candeloro, M Di Nisio, A Ponzano, GM Tiboni, N Potere, M Tana, ... Frontiers in endocrinology 11, 594867, 2020 | 14 | 2020 |
